This size is suitable for injecting into the fatty tissue just below the skin
Tirzepatide (Zepbound and Mounjaro): Weekly GLP-1/GIP injection Tirzepatide is a dual GLP-1 and GIP receptor agonist that mimics the activity of two natural hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, that regulate your appetite and metabolism
Finishing phase (weeks 9 to 12): BPC-157 continues at 250mcg daily, TB-500 at 2.5mg once weekly
It is not approved for human use
Each Glow 70mg peptide blend vial contains 50mg GHK-Cu (Copper Tripeptide-1), 10mg BPC-157 (synthetic pentadecapeptide), and 10mg TB-500 (Thymosin Beta-4 fragment) giving a total of 70mg per vial
Less common: Mild nausea, headache, or temporary fatigue